Navigation Links
Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
Date:12/20/2011

igenexpress.com/">www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements
This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015  Perrigo Company plc ("Perrigo") (NYSE: PRGO ... acquisition of leading OTC brands from GSK in an ... is a clear demonstration of Perrigo,s unique ability to ... network spanning 36 countries.  Perrigo Chairman, ... "We are excited to complete this transaction, which clearly ...
(Date:8/28/2015)... India , August 28, 2015 ... Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ... , Asia-Pacific , and Rest of the ... MarketsandMarkets, The global market for Eubiotics was valued at USD ... 7.05 Billion by 2020, at a CAGR of 7.4% from ...
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... NANJING, China, Oct. 29 /PRNewswire-Asia/ ... or the "Company"), a leading pharmaceutical company,specializing in ... proprietary pharmaceuticals in China, today announced that it ... stake in ChinaVax, a Cayman,Islands company that, as ...
... Biotech, LLC, a corporation based in Hopkinton, Massachusetts, and ... its current sales managers, William Heppner of Illinois, David ... were charged today in federal court with participating in ... invasive spinal and long bone surgeries. Stryker Biotech and ...
Cached Medicine Technology:Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 2Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 3Stryker Biotech and its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries 2Stryker Biotech and its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries 3
(Date:8/28/2015)... ... August 28, 2015 , ... CARF ... its adolescent residential, counseling, day treatment and intensive family based services. , By ... for quality and its pursuit of excellence. As a nonprofit charity for more ...
(Date:8/28/2015)... IL (PRWEB) , ... August 28, 2015 , ... Mendon, ... evening of good music and good people, all for a good cause. In its ... 30th, 2015, sponsored once more by Best Drug Rehabilitation. The “Mission” of “Music With ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Database have added comprehensive information on two new duals programs: Rhode Island ... 2015 launch; and Idaho’s partnership to revamp Blue Cross of Idaho’s D-SNP. ...
(Date:8/28/2015)... ... August 28, 2015 , ... Yisrayl Hawkins, Pastor and ... and pleads for swift actions to be taken in order to ease the ... , Yisrayl says scientists have yet to understand fully the real cause of global ...
(Date:8/28/2015)... ... August 28, 2015 , ... Where ... and marriage? , MillionaireMatchmakerOnline.net is set up to help quality singles find dating ... on the site are rich, gorgeous, well educated, or attractive. , It updates ...
Breaking Medicine News(10 mins):Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:Wake Up and Smell the Sick Atmosphere Says Yisrayl Hawkins in New Article This Week 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3
... Inc.,(Nasdaq: ATRC ), a medical device company and ... David J. Drachman, President and,Chief Executive Officer, is scheduled ... Growth Stock Conference at the Ritz Carlton Laguna,Niguel in ... p.m.,PT., A live web cast and recording of ...
... HPV-positive tumors tend to survive longer and are more ... according to a study published online February 12 in ... , Human papillomavirus has been shown to be ... cancers, particularly cancers of the upper throat, or oropharynx. ...
... Breast Cancer Survivors , Breast cancer survivors, ... death from non-cancer causes than from breast cancer. ... are surviving longer, and many are dying of ... and colleagues with the National Cancer Institute of ...
... 12, 2008 -- In a study to examine the impact ... subjects report over one month, researchers at Columbia University Mailman ... less was a more accurate predictor of physically and mentally ... desire to lose weight was more predictive of unhealthy days ...
... those with HPV-negative tumors , , TUESDAY, Feb. 12 (HealthDay ... test positive for human papillomavirus (HPV) tend to survive ... test negative, a new study says. , HPV, a ... most cervical cancers, has recently been linked to the ...
... the research offers , , TUESDAY, Feb. 12 (HealthDay ... of the most pressing questions in critical care medicine: ... the partially collapsed lungs of people being treated for ... Unfortunately, that question has not been definitively answered. Two ...
Cached Medicine News:Health News:AtriCure to Present at Roth Capital Partners 20th Annual OC Conference 2Health News:Other highlights in the Feb. 12 JNCI 2Health News:Other highlights in the Feb. 12 JNCI 3Health News:Other highlights in the Feb. 12 JNCI 4Health News:Body image is stronger predictor of health than obesity, says Mailman School of PH study 2Health News: Respiratory Distress Treatment Studies Conflict 2Health News: Respiratory Distress Treatment Studies Conflict 3
... The Precision PCx point of ... a whole-blood, patient-side testing system for ... use, the system provides fast, accurate ... hospital and laboratory information systems enables ...
... Analyzer (PCA) is used in conjunction ... a variety of parameters in whole ... 50 patient records and permits on-screen ... as transmission of records to a ...
... left-heart lead is for use with cardiac ... an angled shape and can be inserted ... delivery method, giving physicians an extra option ... in a variety of difficult venous anatomies. ...
Ideal for use with our High Beam headlight. Rotating Turret allows use with other manufacturer's cables. Infinite intensity control. Excellent color definition (6000 K Color Temperature)....
Medicine Products: